The abstract is read at the publisher; the summary is JClub's.
In orthotopic head and neck squamous cell carcinoma models, targeting CGRP signaling—via Calca knockout plus radioimmunotherapy—eradicates tumors and reduces Treg infiltration and immunosuppressive function in Calca knockout mice.
- Why it matters: Sensory-neuroimmune signaling can shape immune “cold” tumor microenvironments that resist therapy, but the specific role of CGRP-driven neurogenic inflammation in HNSCC remained unclear.
- What they did: The study used orthotopic HNSCC models to test sensory signaling interruption, Calca genetic knockout, and pairing with radioimmunotherapy; it also evaluated high-dose psilocybin as a CGRP inhibitor and measured immune changes, including in vitro psilocin effects and human plasma correlations after a single-dose.
- The result: CGRP pathway disruption reduced Treg infiltration and suppressive function and enabled eradication with Calca knockout plus radioimmunotherapy, while psilocybin transiently reduced tumor growth by increasing antitumor immunity and modulating serotonin-linked signaling.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.